Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Other literature type . 2022
License: CC BY
Data sources: ZENODO
ZENODO
Patent . 2022
License: CC BY
Data sources: Datacite
ZENODO
Patent . 2022
License: CC BY
Data sources: Datacite
versions View all 2 versions
addClaim

Formulations comprising ratfish liver oil or a product of an enzymatic or chemical glycerolysis processing of ratfish liver oil and supercritical rosemary extract and uses thereof

Authors: Torres Olivares, Carlos; Vázquez De Frutos, Luis; Corzo, Marta; Arranz, Pablo; Ramírez De Molina, Ana; Reglero Rada, Guillermo; Loria Kohen, Viviana; +7 Authors

Formulations comprising ratfish liver oil or a product of an enzymatic or chemical glycerolysis processing of ratfish liver oil and supercritical rosemary extract and uses thereof

Abstract

Patent number: US-11478008-B2 Abstract: The present disclosure provides compositions comprising a supercritical rosemary extract and a lipid system comprising raffish liver oil or the product of an enzymatic or chemical glycerolysis processing of ratfish liver oil. The present disclosure also provides use of said compositions for immunotherapy potentiators or adjuvants for patients with cancer or immunological disorders; treatment of autoimmune-based immunological disorder selected from the group consisting of: rheumatoid arthritis, type I diabetes, psoriasis, celiac disease and multiple sclerosis; treatment of tumor growth, chronic lymphocytic choriomeningitis virus infection, hepatitis (B and C) virus infection, or human immunodeficiency virus infection; or prevention of kidney damage. Type: Grant Filed: April 28, 2017 Date of Patent: October 25, 2022 Assignees: UNIVERSIDAD AUTÓNOMA DE MADRID, IMDEA ALIMENTACIÓN, HOSPITAL UNIVERSITARIO INFANTA SOFIA Inventors: Carlos Torres Olivares, Luis Vázquez De Frutos, Marta Corzo, Pablo Arranz, Ana Ramírez De Molina, Guillermo Reglero Rada, Viviana Loria Kohen, Marta Gómez De Cedrón, Juan Moreno Rubio, José Moisés Laparra Llopis, Enrique Casado Sáenz

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
Green
Related to Research communities
Cancer Research